Geneva Network research is quoted in this IPWatchdog article examining whether the IP provisions in the USMCA will raise medicine prices. Post navigation Previous Article Previous Article Civil society statement on the EU’s intellectual property incentives review Next Article Next Article Geneva Network and IDEAS joint roundtable on IP reform in Malaysia You may also like Building a pro-intellectual property community in Brazil News Why Voluntary Licensing is Best for Increasing Access to Medicines News